A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies
Article
[키워드] abrogated
acute respiratory syndrome
addition
Analysis
antibodies
antibody
Antiviral
antiviral drugs
authorization
BNT162b2
clinical benefits
Clinical data
clinical trial
coronavirus
COVID-19
Critical
diagnostic
distribution
drug
drugs
Effect
Effectiveness
Efficacy
effort
Emergency
global public health
help
Infection
mRNA vaccines
mRNA-1273
mutant strain
Mutation
Neutralizing antibodies
neutralizing antibody
neutralizing effect
novel coronavirus disease
omicron
overcome
pandemic
presenting
problems
Regulatory
SARS-CoV-2
SARS-CoV-2 strains
SARS-CoV-2 variant
Scientific community
shown
small molecule
Small molecule antiviral drugs
small molecule drugs
Support
the spike protein
therapeutic
Therapeutics
Treatment
utility
Vaccine
Vaccine development
Vaccines
variant
variants
widespread
[DOI] 10.1186/s12929-022-00852-9 PMC 바로가기
[DOI] 10.1186/s12929-022-00852-9 PMC 바로가기